David Rosner
David Rosner
Gail Wilensky
Gail Wilensky
UNAIDS 90-90-90 Campaign to End the AIDS Epidemic in Historic Perspective [0.03%]
联合国艾滋病规划署发起“90-90-90行动”以历史视角终结艾滋病流行
Powel Kazanjian
Powel Kazanjian
Lawrence O Gostin
Lawrence O Gostin
Timing and Characteristics of Cumulative Evidence Available on Novel Therapeutic Agents Receiving Food and Drug Administration Accelerated Approval [0.03%]
美国食品药品监督管理局加速批准的新型药物治疗剂累积证据的可用性及其特征和发展时间表分析
Huseyin Naci,Olivier J Wouters,Radhika Gupta et al.
Huseyin Naci et al.
Policy Points: Randomized trials-the gold standard of evaluating effectiveness-constitute a small minority of existing evidence on agents given accelerated approval. One-third of randomized trials are in therapeutic areas outside of FDA app...
Sara Rosenbaum
Sara Rosenbaum
Sandro Galea
Sandro Galea
Déjà Vu at the FDA [0.03%]
FDA再现虚惊一事
Joshua Sharfstein
Joshua Sharfstein
John E McDONOUGH
John E McDONOUGH
Measuring, Reporting, and Rewarding Quality of Care in 5 Nations: 5 Policy Levers to Enhance Hospital Quality Accountability [0.03%]
五国医疗保健系统中的医院质量问责：测量、报告和激励措施
Christoph Pross,Alexander Geissler,Reinhard Busse
Christoph Pross
Comparative Study
The Milbank quarterly. 2017 Mar;95(1):136-183. DOI:10.1111/1468-0009.12248 2017